Effect of TRPC6 knockdown on puromycin aminonucleoside-induced podocyte injury

Abstract

This study was aimed to construct eukaryotic expression vectors carrying the small hairpin RNA (shRNA) targeting TRPC6 gene and investigate the effect of TRPC6 knockdown on puromucin aminonucleoside (PAN)-induced podocyte injury. Two DNA sequences containing the small hairpin structure targeting TRPC6 were designed, synthesized and then inserted into the green fluorescence protein (GFP)-contained plasmids (pGC) to establish the plasmids pGCsi-TRPC6A and pGCsi-TRPC6B. Plasmids expressing scrambled shRNA were used as negative control and named pGCsi-NC. These plasmids were transfected into a conditionally immortalized murine podocyte cell line by using liposome. Flow cytometry was used to examine the transfection efficiency. TRPC6 mRNA and protein expression levels were detected by RT-PCR and Western blotting. Cultured podocytes were divided into four groups: control group, PAN treatment group, PAN+TRPC6 shRNA transfected group and PAN+scrambled shRNA transfected group. The paracelluar permeability to BSA was evaluated by Millicell-PCF Inserts and cell viability was measured by the trypan blue assay. Immunofluorescent assay was used to observe the distribution of α-actinin-4 and α-tubulin. The results showed that the transfection efficiency of the shRNA expression vector was about 45%. Expression levels of TRPC6 mRNA and protein were downregulated after transfection with pGCsi-TRPC6A and pGCsi-TRPC6B. Knocking down TRPC6 gene could effectively reverse the PAN-induced increase in the paracelluar permeability to BSA. The distribution of α-actinin-4 and α-tubulin was disrupted after treatment with PAN, which was reversed by knocking down TRPC6 gene. It was concluded that knocking down TRPC6 gene could effectively prevent podocytes from the permeability increase induced by PAN, which may be related to the regulation of podocyte cytoskeleton.

Keywords

TRPC6 / puromycin aminonucleoside / podocyte / permeability / cytoskeleton

References

[1] LiakopoulosV., HuertaA., CohenS., et al.. Familial collapsing focal segmental glomerulosclerosis. Clin Nephrol, 2011, 75(4): 362-368

[2] WinnM.P., ConlonP.J., LynnK.L., et al.. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science, 2005, 308(5729): 1801-1804

[3] ReiserJ., PoluK.R., MollerC.C., et al.. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet, 2005, 37(7): 739-744

[4] EckelJ., LavinP.J., FinchE.A., et al.. TRPC6 enhances angiotensin II-induced albuminuria. Am Soc Nephrol, 2011, 22(3): 526-535

[5] MollerC.C., WeiC., AltintasM.M., et al.. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol, 2007, 18(1): 29-36

[6] JiangH.J., ChangY., ZhuZ.H., et al.. Role of CD2-associated protein in podocyte differentiation. Sheng Li Xue Bao (Chinese), 2008, 60(1): 135-142

[7] ZhangC., JiangH.J., ChangY., et al.. Downregulation of CD2-associated protein impaired the physiological functions of podocytes. Cell Biol Int, 2009, 33(6): 632-639

[8] LiX., YuanH., ZhangX.. Adriamycin increases podocyte permeability: evidence and molecular mechanism. Chin Med J, 2003, 116(12): 1831-1835

[9] ElbashirS.M., HarborthJ., LendeckelW., et al.. Duplexes of 21 nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411(6836): 494-498

[10] BrummelkampT.R., BemardsR., AgamiR., et al.. A system for stable expression of short interfering RNAi in mammalan cells. Science, 2002, 296(5567): 550-553

[11] KimY.H., GoyalM., KurnitD., et al.. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int, 2001, 60(3): 957-968

[12] WenD., YouL., ZhangQ., et al.. Upregulation of nestin protects podocytes from apoptosis induced by puromycin aminonucleoside. Am J Nephrol, 2011, 34(5): 423-434

[13] ReiserJ., OhJ., ShiratoI., et al.. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin. J Biol Chem, 2004, 279(33): 34827-34832

[14] HuntJ.L., PollakM.R., DenkerB.M., et al.. Cultured podocytes establish a size-selective barrier regulated by specific signaling pathways and demonstrate synchronized barrier assembly in a calcium switch model of junction formation. J Am Soc Nephrol, 2005, 16(6): 1593-1602

[15] SunX., FangZ., ZhuZ., et al.. Effect of Down-regulation of TRPC6 on puromycin aminonucleoside-induced apoptosis of mouse podocyte. J Huazhong Univ Sci Technolog [Med Sci], 2009, 29(4): 417-422

[16] KanplanJ., KimS., NorthK., et al.. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet, 2000, 24(3): 251-256

[17] ZhangC., JiangH., ChangY., et al.. Knocking-down CD2AP gene expression inhibits the proliferation and blocks the division of podocytes. Chin J Nephro (Chinese), 2007, 23(12): 778-783

[18] SunX., ZhangC., FangZ., et al.. Effect of TRPC6 overexpression on slit diaphragm-associated molecules and cytoskeleton of podocytes in mouse. Chin J Nepthrol (Chinese), 2009, 25(7): 519-521